GILD
Gilead Sciences, Inc. (GILD) Investor Questions
Review Gilead Sciences, Inc. (GILD) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Gilead Sciences, Inc.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Overall BTI score
- 64
- Annual revenue
- $29.44B
- Annual net income
- $8.51B
- Annual free cash flow
- $9.46B
Gilead Sciences, Inc. (GILD) Investor Questions research
Gilead Sciences, Inc. trades under the ticker GILD. The company is classified in the Healthcare sector and the Drug Manufacturers - General industry.
Investors commonly review GILD through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.